Drug Administration ScheduleTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsInjections, IntravenousDrug Therapy, CombinationFluorouracilDose-Response Relationship, DrugCyclophosphamideTime FactorsLeucovorinDeglutitionVincristineDoxorubicinAdministration, OralCombined Modality TherapySurvival AnalysisCisplatinEtoposideAnti-HIV AgentsDisease-Free SurvivalProspective StudiesDouble-Blind MethodInfusions, IntravenousAntineoplastic AgentsHIV InfectionsOrganoplatinum CompoundsSurvival RatePrednisoneMethotrexateRetrospective StudiesDeoxycytidineAnti-Bacterial AgentsRemission InductionAnimal Identification SystemsDrug CombinationsSalvage TherapyArea Under CurveTransplantation ConditioningTreatment FailureVinblastineRecurrenceFollow-Up StudiesImmunosuppressive AgentsCytarabineDrug EvaluationHalf-LifeCamptothecinInfusions, ParenteralClinical Trials as TopicPaclitaxelAntiretroviral Therapy, Highly ActiveBusulfanIfosfamideNauseaPatient ComplianceBenzoxazinesHematopoietic Stem Cell TransplantationAntimetabolites, AntineoplasticTaxoidsDrug Dosage CalculationsVidarabineAntitubercular AgentsHIV Protease InhibitorsInfusion PumpsVomitingLymphoma, Non-HodgkinCarboplatinEpirubicinNeutropeniaBleomycinRandom AllocationChemotherapy, AdjuvantMetabolic Clearance RateRifampinRitonavirCross-Over StudiesViral LoadInjections, SubcutaneousAntibodies, MonoclonalTransplantation, AutologousWhole-Body IrradiationReverse Transcriptase InhibitorsPilot ProjectsPrognosisNeoplasm StagingAntineoplastic Agents, AlkylatingLeukopeniaColorectal NeoplasmsTransplantation, HomologousNevirapineNeoplasm MetastasisBone Marrow TransplantationAnesthetics, IntravenousAmoxicillinRandomized Controlled Trials as TopicLung NeoplasmsBlood PressureMelphalanPyrazinamideNeoplasms